ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 662251 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 662251; 2) Community: the network communities that were significantly associated with the response to NSC 662251; 3) Molecule: the relationships between components within communities and NSC 662251; 4) MDR: the compounds that were significantly associated with the NSC 662251.

NSC Compound Enrichment Correlation
NSC 737226 Null 0.0062362367141553 0.36766834
NSC 106442 Null 0.0065871594677386 0.32094758
NSC 29459 Quinoline, 4-[.alpha.-[bis(2-chloroethyl)amino]-4-methoxy-m-toluidino]-7-chloro-, dihydrochloride 0.0065871594677386 -0.037942195
NSC 35753 Pyrocatechol, 4,4'-(meso-1,2-diethylethylene)di- 0.0065871594677386 0.37870532
NSC 624227 Null 0.0065871594677386 0.15239423
NSC 677003 Null 0.0065871594677386 0.19056447
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.0065871594677386 0.17008613
NSC 684909 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 0.0065871594677386 0.22392251
NSC 685988 Dihydroartemisinyl ether, stereoisomer of NSC-685989 0.0065871594677386 0.47825118
NSC 701555 2,3-Dihydro-1,2-syn-3-[phenylseleno]brefeldin A 0.0065871594677386 -0.061663407
Total:93  Current:17    [First] [Prev] [Next] [Last]